Global Mantle Cell Lymphoma Treatment Market Research Report 2018

Publisher : QY Research Reports Publication Date : Jan 04, 2018

Number of Pages : 116 Subcategory : Healthcare
Single User $ 2900
Global User $ 5800

Want to have a look at sample?

Request sample

Want to check today's discount?

Enquiry for Discount
  • Description

    Product Description

    In this report, the global Mantle Cell Lymphoma Treatment market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

    Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Mantle Cell Lymphoma Treatment in these regions, from 2013 to 2025 (forecast), covering
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
    Global Mantle Cell Lymphoma Treatment market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
    Astex Pharmaceuticals, Inc.
    Bayer AG
    Bristol-Myers Squibb Company
    Celgene Corporation
    Cellular Biomedicine Group, Inc.
    Eisai
    EpiZyme, Inc.
    Fate Therapeutics, Inc.
    Genentech, Inc.
    Gilead Sciences, Inc.
    GlaxoSmithKline Plc
    Hutchison MediPharma Limited
    ImmunoGen, Inc.
    Immunomedics, Inc.
    On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Acalabrutinib
    JCAR-017
    JNJ-64052781
    Acalisib
    IGN-002
    IMGN-529
    AFM-11
    Others
    On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
    Hospital
    Clinic
    Others

    If you have any special requirements, please let us know and we will offer you the report as you want.

  • Table of Content

    Global Mantle Cell Lymphoma Treatment Market Research Report 2018

    Table of Contents

    Global Mantle Cell Lymphoma Treatment Market Research Report 2018
    1 Mantle Cell Lymphoma Treatment Market Overview
    1.1 Product Overview and Scope of Mantle Cell Lymphoma Treatment
    1.2 Mantle Cell Lymphoma Treatment Segment by Type (Product Category)
    1.2.1 Global Mantle Cell Lymphoma Treatment Production and CAGR (%) Comparison by Type (Product Category)(2013-2025)
    1.2.2 Global Mantle Cell Lymphoma Treatment Production Market Share by Type (Product Category) in 2017
    1.2.3 Acalabrutinib
    1.2.4 JCAR-017
    1.2.5 JNJ-64052781
    1.2.6 Acalisib
    1.2.7 IGN-002
    1.2.8 IMGN-529
    1.2.9 AFM-11
    1.2.10 Others
    1.3 Global Mantle Cell Lymphoma Treatment Segment by Application
    1.3.1 Mantle Cell Lymphoma Treatment Consumption (Sales) Comparison by Application (2013-2025)
    1.3.2 Hospital
    1.3.3 Clinic
    1.3.4 Others
    1.4 Global Mantle Cell Lymphoma Treatment Market by Region (2013-2025)
    1.4.1 Global Mantle Cell Lymphoma Treatment Market Size (Value) and CAGR (%) Comparison by Region (2013-2025)
    1.4.2 North America Status and Prospect (2013-2025)
    1.4.3 Europe Status and Prospect (2013-2025)
    1.4.4 China Status and Prospect (2013-2025)
    1.4.5 Japan Status and Prospect (2013-2025)
    1.4.6 Southeast Asia Status and Prospect (2013-2025)
    1.4.7 India Status and Prospect (2013-2025)
    1.5 Global Market Size (Value) of Mantle Cell Lymphoma Treatment (2013-2025)
    1.5.1 Global Mantle Cell Lymphoma Treatment Revenue Status and Outlook (2013-2025)
    1.5.2 Global Mantle Cell Lymphoma Treatment Capacity, Production Status and Outlook (2013-2025)

    2 Global Mantle Cell Lymphoma Treatment Market Competition by Manufacturers
    2.1 Global Mantle Cell Lymphoma Treatment Capacity, Production and Share by Manufacturers (2013-2018)
    2.1.1 Global Mantle Cell Lymphoma Treatment Capacity and Share by Manufacturers (2013-2018)
    2.1.2 Global Mantle Cell Lymphoma Treatment Production and Share by Manufacturers (2013-2018)
    2.2 Global Mantle Cell Lymphoma Treatment Revenue and Share by Manufacturers (2013-2018)
    2.3 Global Mantle Cell Lymphoma Treatment Average Price by Manufacturers (2013-2018)
    2.4 Manufacturers Mantle Cell Lymphoma Treatment Manufacturing Base Distribution, Sales Area and Product Type
    2.5 Mantle Cell Lymphoma Treatment Market Competitive Situation and Trends
    2.5.1 Mantle Cell Lymphoma Treatment Market Concentration Rate
    2.5.2 Mantle Cell Lymphoma Treatment Market Share of Top 3 and Top 5 Manufacturers
    2.5.3 Mergers & Acquisitions, Expansion

    3 Global Mantle Cell Lymphoma Treatment Capacity, Production, Revenue (Value) by Region (2013-2018)
    3.1 Global Mantle Cell Lymphoma Treatment Capacity and Market Share by Region (2013-2018)
    3.2 Global Mantle Cell Lymphoma Treatment Production and Market Share by Region (2013-2018)
    3.3 Global Mantle Cell Lymphoma Treatment Revenue (Value) and Market Share by Region (2013-2018)
    3.4 Global Mantle Cell Lymphoma Treatment Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
    3.5 North America Mantle Cell Lymphoma Treatment Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
    3.6 Europe Mantle Cell Lymphoma Treatment Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
    3.7 China Mantle Cell Lymphoma Treatment Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
    3.8 Japan Mantle Cell Lymphoma Treatment Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
    3.9 Southeast Asia Mantle Cell Lymphoma Treatment Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
    3.10 India Mantle Cell Lymphoma Treatment Capacity, Production, Revenue, Price and Gross Margin (2013-2018)

    4 Global Mantle Cell Lymphoma Treatment Supply (Production), Consumption, Export, Import by Region (2013-2018)
    4.1 Global Mantle Cell Lymphoma Treatment Consumption by Region (2013-2018)
    4.2 North America Mantle Cell Lymphoma Treatment Production, Consumption, Export, Import (2013-2018)
    4.3 Europe Mantle Cell Lymphoma Treatment Production, Consumption, Export, Import (2013-2018)
    4.4 China Mantle Cell Lymphoma Treatment Production, Consumption, Export, Import (2013-2018)
    4.5 Japan Mantle Cell Lymphoma Treatment Production, Consumption, Export, Import (2013-2018)
    4.6 Southeast Asia Mantle Cell Lymphoma Treatment Production, Consumption, Export, Import (2013-2018)
    4.7 India Mantle Cell Lymphoma Treatment Production, Consumption, Export, Import (2013-2018)

    5 Global Mantle Cell Lymphoma Treatment Production, Revenue (Value), Price Trend by Type
    5.1 Global Mantle Cell Lymphoma Treatment Production and Market Share by Type (2013-2018)
    5.2 Global Mantle Cell Lymphoma Treatment Revenue and Market Share by Type (2013-2018)
    5.3 Global Mantle Cell Lymphoma Treatment Price by Type (2013-2018)
    5.4 Global Mantle Cell Lymphoma Treatment Production Growth by Type (2013-2018)

    6 Global Mantle Cell Lymphoma Treatment Market Analysis by Application
    6.1 Global Mantle Cell Lymphoma Treatment Consumption and Market Share by Application (2013-2018)
    6.2 Global Mantle Cell Lymphoma Treatment Consumption Growth Rate by Application (2013-2018)
    6.3 Market Drivers and Opportunities
    6.3.1 Potential Applications
    6.3.2 Emerging Markets/Countries

    7 Global Mantle Cell Lymphoma Treatment Manufacturers Profiles/Analysis
    7.1 Astex Pharmaceuticals, Inc.
    7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
    7.1.2 Mantle Cell Lymphoma Treatment Product Category, Application and Specification
    7.1.2.1 Product A
    7.1.2.2 Product B
    7.1.3 Astex Pharmaceuticals, Inc. Mantle Cell Lymphoma Treatment Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
    7.1.4 Main Business/Business Overview
    7.2 Bayer AG
    7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
    7.2.2 Mantle Cell Lymphoma Treatment Product Category, Application and Specification
    7.2.2.1 Product A
    7.2.2.2 Product B
    7.2.3 Bayer AG Mantle Cell Lymphoma Treatment Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
    7.2.4 Main Business/Business Overview
    7.3 Bristol-Myers Squibb Company
    7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
    7.3.2 Mantle Cell Lymphoma Treatment Product Category, Application and Specification
    7.3.2.1 Product A
    7.3.2.2 Product B
    7.3.3 Bristol-Myers Squibb Company Mantle Cell Lymphoma Treatment Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
    7.3.4 Main Business/Business Overview
    7.4 Celgene Corporation
    7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
    7.4.2 Mantle Cell Lymphoma Treatment Product Category, Application and Specification
    7.4.2.1 Product A
    7.4.2.2 Product B
    7.4.3 Celgene Corporation Mantle Cell Lymphoma Treatment Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
    7.4.4 Main Business/Business Overview
    7.5 Cellular Biomedicine Group, Inc.
    7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
    7.5.2 Mantle Cell Lymphoma Treatment Product Category, Application and Specification
    7.5.2.1 Product A
    7.5.2.2 Product B
    7.5.3 Cellular Biomedicine Group, Inc. Mantle Cell Lymphoma Treatment Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
    7.5.4 Main Business/Business Overview
    7.6 Eisai
    7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
    7.6.2 Mantle Cell Lymphoma Treatment Product Category, Application and Specification
    7.6.2.1 Product A
    7.6.2.2 Product B
    7.6.3 Eisai Mantle Cell Lymphoma Treatment Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
    7.6.4 Main Business/Business Overview
    7.7 EpiZyme, Inc.
    7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
    7.7.2 Mantle Cell Lymphoma Treatment Product Category, Application and Specification
    7.7.2.1 Product A
    7.7.2.2 Product B
    7.7.3 EpiZyme, Inc. Mantle Cell Lymphoma Treatment Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
    7.7.4 Main Business/Business Overview
    7.8 Fate Therapeutics, Inc.
    7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
    7.8.2 Mantle Cell Lymphoma Treatment Product Category, Application and Specification
    7.8.2.1 Product A
    7.8.2.2 Product B
    7.8.3 Fate Therapeutics, Inc. Mantle Cell Lymphoma Treatment Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
    7.8.4 Main Business/Business Overview
    7.9 Genentech, Inc.
    7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
    7.9.2 Mantle Cell Lymphoma Treatment Product Category, Application and Specification
    7.9.2.1 Product A
    7.9.2.2 Product B
    7.9.3 Genentech, Inc. Mantle Cell Lymphoma Treatment Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
    7.9.4 Main Business/Business Overview
    7.10 Gilead Sciences, Inc.
    7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
    7.10.2 Mantle Cell Lymphoma Treatment Product Category, Application and Specification
    7.10.2.1 Product A
    7.10.2.2 Product B
    7.10.3 Gilead Sciences, Inc. Mantle Cell Lymphoma Treatment Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
    7.10.4 Main Business/Business Overview
    7.11 GlaxoSmithKline Plc
    7.12 Hutchison MediPharma Limited
    7.13 ImmunoGen, Inc.
    7.14 Immunomedics, Inc.

    8 Mantle Cell Lymphoma Treatment Manufacturing Cost Analysis
    8.1 Mantle Cell Lymphoma Treatment Key Raw Materials Analysis
    8.1.1 Key Raw Materials
    8.1.2 Price Trend of Key Raw Materials
    8.1.3 Key Suppliers of Raw Materials
    8.1.4 Market Concentration Rate of Raw Materials
    8.2 Proportion of Manufacturing Cost Structure
    8.2.1 Raw Materials
    8.2.2 Labor Cost
    8.2.3 Manufacturing Expenses
    8.3 Manufacturing Process Analysis of Mantle Cell Lymphoma Treatment

    9 Industrial Chain, Sourcing Strategy and Downstream Buyers
    9.1 Mantle Cell Lymphoma Treatment Industrial Chain Analysis
    9.2 Upstream Raw Materials Sourcing
    9.3 Raw Materials Sources of Mantle Cell Lymphoma Treatment Major Manufacturers in 2017
    9.4 Downstream Buyers

    10 Marketing Strategy Analysis, Distributors/Traders
    10.1 Marketing Channel
    10.1.1 Direct Marketing
    10.1.2 Indirect Marketing
    10.1.3 Marketing Channel Development Trend
    10.2 Market Positioning
    10.2.1 Pricing Strategy
    10.2.2 Brand Strategy
    10.2.3 Target Client
    10.3 Distributors/Traders List

    11 Market Effect Factors Analysis
    11.1 Technology Progress/Risk
    11.1.1 Substitutes Threat
    11.1.2 Technology Progress in Related Industry
    11.2 Consumer Needs/Customer Preference Change
    11.3 Economic/Political Environmental Change

    12 Global Mantle Cell Lymphoma Treatment Market Forecast (2018-2025)
    12.1 Global Mantle Cell Lymphoma Treatment Capacity, Production, Revenue Forecast (2018-2025)
    12.1.1 Global Mantle Cell Lymphoma Treatment Capacity, Production and Growth Rate Forecast (2018-2025)
    12.1.2 Global Mantle Cell Lymphoma Treatment Revenue and Growth Rate Forecast (2018-2025)
    12.1.3 Global Mantle Cell Lymphoma Treatment Price and Trend Forecast (2018-2025)
    12.2 Global Mantle Cell Lymphoma Treatment Production, Consumption , Import and Export Forecast by Region (2018-2025)
    12.2.1 North America Mantle Cell Lymphoma Treatment Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
    12.2.2 Europe Mantle Cell Lymphoma Treatment Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
    12.2.3 China Mantle Cell Lymphoma Treatment Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
    12.2.4 Japan Mantle Cell Lymphoma Treatment Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
    12.2.5 Southeast Asia Mantle Cell Lymphoma Treatment Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
    12.2.6 India Mantle Cell Lymphoma Treatment Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
    12.3 Global Mantle Cell Lymphoma Treatment Production, Revenue and Price Forecast by Type (2018-2025)
    12.4 Global Mantle Cell Lymphoma Treatment Consumption Forecast by Application (2018-2025)

    13 Research Findings and Conclusion

    14 Appendix
    14.1 Methodology/Research Approach
    14.1.1 Research Programs/Design
    14.1.2 Market Size Estimation
    14.1.3 Market Breakdown and Data Triangulation
    14.2 Data Source
    14.2.1 Secondary Sources
    14.2.2 Primary Sources
    14.3 Disclaimer


  • Pre-sales Enquiry

    The free sample report is clearly a representation of the complete report. Buy report to get the complete market scope/data depth information.